LTRN vs. ROKT
LTRN (Lantern Pharma Inc.) is a stock, while ROKT (SPDR S&P Kensho Final Frontiers ETF) is Industrials Equities fund tracking the S&P Kensho Final Frontiers Index. Over the past 5 years, LTRN returned -23.69%/yr vs 22.83%/yr for ROKT. At a 0.28 correlation, their price movements are largely independent.
Performance
LTRN vs. ROKT - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, LTRN achieves a 28.05% return, which is significantly lower than ROKT's 35.59% return.
LTRN
- 1D
- 2.37%
- 1M
- 10.86%
- YTD
- 28.05%
- 6M
- 7.78%
- 1Y
- 22.01%
- 3Y*
- -8.83%
- 5Y*
- -23.69%
- 10Y*
- —
ROKT
- 1D
- -1.94%
- 1M
- -8.05%
- YTD
- 35.59%
- 6M
- 31.63%
- 1Y
- 88.44%
- 3Y*
- 40.42%
- 5Y*
- 22.83%
- 10Y*
- —
LTRN vs. ROKT - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
LTRN Lantern Pharma Inc. | 28.05% | -5.02% | -25.47% | -29.14% | -24.31% | -58.55% | 30.07% |
ROKT SPDR S&P Kensho Final Frontiers ETF | 35.59% | 50.56% | 27.89% | 14.41% | -0.81% | 4.63% | 19.15% |
Correlation
The correlation between LTRN and ROKT is 0.32, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.32 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.29 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.30 |
Correlation (All Time) Calculated using the full available price history since Jun 11, 2020 | 0.28 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
LTRN vs. ROKT — Risk / Return Rank
LTRN
ROKT
LTRN vs. ROKT - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Lantern Pharma Inc. (LTRN) and SPDR S&P Kensho Final Frontiers ETF (ROKT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| LTRN | ROKT | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.63 | ||
| Sortino ratioReturn per unit of downside risk | -2.42 | ||
| Omega ratioGain probability vs. loss probability | 1.15 | 1.44 | -0.29 |
| Calmar ratioReturn relative to maximum drawdown | 0.28 | 5.68 | -5.40 |
| Martin ratioReturn relative to average drawdown | 0.59 | 21.13 | -20.54 |
Loading charts...
Drawdowns
LTRN vs. ROKT - Drawdown Comparison
The maximum LTRN drawdown since its inception was -94.89%, which is greater than ROKT's maximum drawdown of -43.16%. Use the drawdown chart below to compare losses from any high point for LTRN and ROKT.
Loading charts...
Drawdown Indicators
| LTRN | ROKT | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -94.89% | -43.16% | -51.73% |
Max Drawdown (1Y)Largest decline over 1 year | -78.95% | -15.64% | -63.31% |
Max Drawdown (3Y)Largest decline over 3 years | -89.48% | -23.46% | -66.02% |
Max Drawdown (5Y)Largest decline over 5 years | -92.66% | -23.46% | -69.20% |
Current DrawdownCurrent decline from peak | -82.30% | -15.64% | -66.66% |
Average DrawdownAverage peak-to-trough decline | -66.29% | -6.79% | -59.50% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 37.57% | 4.20% | +33.37% |
Volatility
LTRN vs. ROKT - Volatility Comparison
Lantern Pharma Inc. (LTRN) has a higher volatility of 22.47% compared to SPDR S&P Kensho Final Frontiers ETF (ROKT) at 15.53%. This indicates that LTRN's price experiences larger fluctuations and is considered to be riskier than ROKT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| LTRN | ROKT | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 22.47% | 15.53% | +6.94% |
Volatility (6M)Calculated over the trailing 6-month period | 90.44% | 26.89% | +63.55% |
Volatility (1Y)Calculated over the trailing 1-year period | 98.04% | 31.22% | +66.82% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 85.61% | 23.36% | +62.25% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 85.12% | 25.41% | +59.71% |
Dividends
LTRN vs. ROKT - Dividend Comparison
LTRN has not paid dividends to shareholders, while ROKT's dividend yield for the trailing twelve months is around 0.33%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
LTRN Lantern Pharma Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
ROKT SPDR S&P Kensho Final Frontiers ETF | 0.33% | 0.41% | 0.57% | 0.62% | 0.54% | 1.79% | 0.48% | 0.74% | 0.16% |
Frequently Asked Questions
LTRN and ROKT have a correlation of 0.32, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
LTRN has higher volatility (22.47%) compared to ROKT (15.53%). In terms of maximum drawdown, LTRN dropped -94.89% vs ROKT's -43.16%.
ROKT currently has the higher Sharpe Ratio (2.85 vs 0.23), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for LTRN and ROKT
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer